Article Details
Retrieved on: 2025-08-21 22:08:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The deal gives Gilead ownership of a technology that can genetically modify immune cells inside the body, an approach could potentially widen ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here